Buy & Sell Zoetis Inc (ZTS) – Zoetis Inc Price Today
Aura AI Summary
Key Stats
- $33.30BMarket Cap
- HealthSector
- -39.52%3M Drawdown
- $40.60BEnterprise Value
- 2.67%Dividend Yield
- 71 daysTypical Hold Time
Zoetis Inc (ZTS) is currently valued at a market capitalization of $33.30B, with an enterprise value of $40.60B. Over the past 52 weeks, Zoetis Inc has traded between a low of $74.22 and a high of $170.16, highlighting its annual price range. Over the past three months, Zoetis Inc has recorded a drawdown of -39.52%, reflecting recent price volatility. Zoetis Inc offers a dividend yield of 2.67%, with the most recent dividend of $0.53 paid on 20 Apr 26. On average, investors hold Zoetis Inc for approximately 71 days, indicating typical investor behavior on the platform.
About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Most Recent News
AI boom drives strong earnings beats, policy debates, and major tech moves worldwide
Recent financial reports show strong earnings beats driven by surging demand for artificial intelligence (AI) technologies, with companies like ServiceTitan, Palo Alto Networks, and CrowdStrike exceeding revenue and earnings estimates. Policymakers i...

VanEck marks 20 years of GDX ETF, highlighting its impact on the ETF industry and gold investing.
VanEck celebrates 20 years of its GDX ETF, reflecting on how it transformed the ETF industry and the long-term investment case for gold. The discussion features insights from VanEck CEO Jan van Eck and COO Adam Phillips on the ETF's origin and future...

Healthcare stocks shift from defensive to value plays amid tech-driven market growth.
Healthcare stocks, long underperforming compared to tech, are now seen as value opportunities for investors heavily invested in growth sectors like AI. Mizuho strategist Jared Holz highlights Merck as a prime example, with its strong Keytruda franchi...
